Search

Your search keyword '"NEGLECTED diseases"' showing total 8,071 results

Search Constraints

Start Over You searched for: Descriptor "NEGLECTED diseases" Remove constraint Descriptor: "NEGLECTED diseases"
8,071 results on '"NEGLECTED diseases"'

Search Results

1. Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?

2. Development of α-acyloxycarboxamides targeting Leishmania amazonensis parasite.

3. Mycetoma: A critical appraisal of educational content on YouTube.

4. Accuracy of immunological tests on serum and urine for diagnosis of Taenia solium neurocysticercosis: A systematic review.

5. The Seroepidemiology of Strongyloides stercoralis Infection in Jamaica.

6. Revisiting threats associated with neglected and emerging fungal pathogens in sub-Saharan Africa.

7. Neuro-leishmaniasis with cauda equina syndrome and cranial nerve palsy: a rare manifestation of recurrent atypical visceral leishmaniasis.

8. Buruli ulcer surveillance in south-eastern Australian possums: Infection status, lesion mapping and internal distribution of Mycobacterium ulcerans.

9. Health related quality of life and associated factors among children living in previous leprosarium and nonleprosarium areas of Eastern Ethiopia.

10. Mapping schistosomiasis risk landscapes and implications for disease control: A case study for low endemic areas in the Middle Paranapanema river basin, São Paulo, Brazil.

11. An Overview of Tsetse Fly Repellents: Identification and Applications.

12. Qualitative study of the stigma associated with the lived experiences of Buruli ulcer disease among patients in Nigeria.

13. Fatal Oropouche Virus Infections in Nonendemic Region, Brazil, 2024.

14. Proteomic diversity of Russell's viper venom: exploring PLA2 isoforms, pharmacological effects, and inhibitory approaches.

15. Single-stranded DNA oligonucleotides containing CpG motifs are non-stimulatory in vitro but offer protection in vivo against Burkholderia pseudomallei.

16. Survival analysis of adult visceral leishmaniasis patients admitted to Metema Hospital, Metema, Ethiopia: a hospital-based cross-sectional study.

17. Spatiotemporal Distribution of Human Rabies and Identification of Predominant Risk Factors in China from 2004 to 2020.

18. Bacterial microbiota from the gut of Rhodnius ecuadoriensis, a vector of Chagas disease in Ecuador’s Central Coast and Southern Andes J.

19. Crystal structure of the HMGA AT-hook 1 domain bound to the minor groove of AT-rich DNA and inhibition by antikinetoplastid drugs.

20. High prevalence of intestinal schistosomiasis in school-age children in the villages adjacent to Lake Chamo in the southern Rift Valley of Ethiopia.

21. Virulome and phylogenomic profiling of a novel Burkholderia pseudomallei strain from an Indian clinical isolate.

22. Uncovering intersecting stigmas experienced by people affected by podoconiosis in Nyamasheke district, Rwanda.

23. Investigation of parasite genetic variation and systemic immune responses in patients presenting with different clinical presentations of cutaneous leishmaniasis caused by Leishmania aethiopica.

24. A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group.

25. General public knowledge, attitudes, and practices about rabies and associated factors in Gomma district of Jimma zone, southwestern Ethiopia.

26. Detection of human strongyloidiasis among patients with a high risk of complications attending selected tertiary care hospitals in Colombo, Sri Lanka using molecular and serological diagnostic tools.

27. Molecular xenomonitoring reveals Anopheles funestus and An. rivulorum as the primary vectors of lymphatic filariasis in coastal Kenya.

28. Classical and innovative drugs for the treatment of Leishmania infections.

29. Transition and change: opportunities and challenges of CHW programme reform for community health systems and vertical disease programmes in Liberia.

30. Community-Based Mycetoma Surveillance in Uganda: Identifying Knowledge Gaps and Training of Community Health Workers to Improve Case Detection.

31. Use of an inertial sensor and a force platform to assess static balance in participants affected by multibacillary leprosy.

32. Evaluating alternative compounds for strongyloidiasis therapy: Novel insights from larval migration inhibition test.

33. An integrated active case detection and management of skin NTDs in yaws endemic health districts in Cameroon, Côte d'Ivoire and Ghana.

34. Type I/II Immune Balance Contributes to the Protective Effect of AIF-1 on Hepatic Immunopathology Induced by Schistosoma japonicum in a Transgenic Mouse Model.

35. Policy and Executive Barriers in Preventing and Eradicating Neglected Tropical Diseases: A Systematic Review.

36. Astrocytes Can Be Key Players Against Cerebral Leishmaniasis: In Vitro Co‐Culture Model for the Assessment of Infection.

37. Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.

38. A low-cost and versatile paramagnetic bead DNA extraction method for Mycobacterium ulcerans environmental surveillance.

39. Quinoxaline 1,4-di- N -oxide Derivatives as New Antinocardial Agents.

40. The role of thematic specialization in international scientific collaboration: the case of Chagas research.

41. Wolbachia infection in natural mosquito populations from Argentina.

42. Computational modeling and molecular dynamics studies of methyl sulfonyl acetate derivatives as potent SmTGR inhibitors: insights into binding interactions.

43. Musculoskeletal involvement in neglected tropical diseases: a comprehensive review.

44. EPIDEMIOLOGIA DOS ACIDENTES OFÍDICOS DO DISTRITO FEDERAL ENTRE 2007 E 2020.

45. Genomic and phenotypic characterization of the Oropouche virus strain implicated in the 2022–24 large‐scale outbreak in Brazil.

46. Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis.

47. Towards enhanced control of mycetoma: a roadmap to achieve the UN's sustainable development goals by 2030.

48. The Impact of Environmental and Housing Factors on the Distribution of Triatominae (Hemiptera, Reduviidae) in an Endemic Area of Chagas Disease in Puebla, Mexico.

49. MARINE NATURAL PRODUCTS AS ANTIVIRAL AGENTS: CURRENT ADVANCES AND FUTURE PERSPECTIVES.

50. Computational Workflow to Design Novel Vaccine Candidates and Small-Molecule Therapeutics for Schistosomiasis.

Catalog

Books, media, physical & digital resources